Correction to: Nature Biotechnology https://doi.org/10.1038/nbt1218-1125, published online 6 December 2018.
In the version of this article initially published, Betalutin was described as directing a radioisotope to CD45-expressing B cells; in fact, it directs it to CD37-expressing B cells. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dolgin, E. Publisher Correction: Radioactive drugs emerge from the shadows to storm the market. Nat Biotechnol 37, 193 (2019). https://doi.org/10.1038/s41587-019-0030-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-019-0030-5
